Abstract | BACKGROUND: METHODS AND RESULTS:
Long-acting natriuretic peptide (LANP), vessel dilator, and kaliuretic peptide (100 ng/kg body weight/min) given intravenously for 60 minutes to NYHA Class III CHF patients (n = 24) increased the albumin excretion rate 2- to 7-fold (P <.001) and total protein excretion rate 2- to 5-fold (P <.001). These peptide hormones similarly enhanced beta(2)-microglobulin, a specific marker of proximal tubular reabsorption, excretion rate 25- to 40-fold (P <.0005) at the end of their respective infusions. Three hours after stopping their respective infusions, the beta(2)-microglobulin excretion rate was still 11- to 33-fold (P <.0005) increased. CONCLUSIONS:
|
Authors | D L Vesely, G I Perez-Lamboy, D D Schocken |
Journal | Journal of cardiac failure
(J Card Fail)
Vol. 7
Issue 1
Pg. 55-63
(Mar 2001)
ISSN: 1071-9164 [Print] United States |
PMID | 11264551
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Peptide Fragments
- Protein Precursors
- Vasodilator Agents
- atrial natriuretic factor precursor (79-98)
- atrial natriuretic factor prohormone (1-30), human
- beta 2-Microglobulin
- Atrial Natriuretic Factor
|
Topics |
- Adult
- Aged
- Albuminuria
(metabolism)
- Atrial Natriuretic Factor
(pharmacology)
- Heart Failure
(metabolism, urine)
- Humans
- Kidney Tubules, Proximal
(metabolism)
- Male
- Middle Aged
- Peptide Fragments
(pharmacology)
- Protein Precursors
(pharmacology)
- Proteinuria
(metabolism)
- Vasodilator Agents
(pharmacology)
- beta 2-Microglobulin
(urine)
|